FDA 510(k)

Lumipulse G pTau217/β-淀粉样蛋白 1-42 血浆比值

K号: K242706 · 2025-05-16

决定日期2025-05-16

产品代码SET

咨询委员会抱歉，您提供的信息不完整，无法进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is the device name listed in this FDA 510(k) record. The listed applicant is Fujirebio Diagnostics,Inc.. It received FDA 510(k) clearance on 2025-05-16 under 510(k) number K242706. The device is classified under product code SET. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio?

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is a medical device that received FDA 510(k) clearance on 2025-05-16. The listed applicant is Fujirebio Diagnostics,Inc.. The 510(k) number is K242706.

When did Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio receive FDA 510(k) clearance?

Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio received FDA 510(k) clearance on 2025-05-16, under 510(k) number K242706.

Who is the listed applicant for Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio?

The FDA 510(k) record lists Fujirebio Diagnostics,Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio?

The FDA product code for Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is SET.

列明Fujirebio Diagnostics,Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K250925ADVIA Centaur 鳞状细胞癌相关抗原21-1 K192524Lumipulse G CA15-3 K192380ST AIA-PACK BNP K200997Lumipulse G CA19-9-N K190702Lumipulse G 全部 PTH K172713Lumipulse G B•R•A•H•M•S PCT 免疫反应卡，Lumipulse G B•R•A•H•M•S PCT 校准器套件

查看所有 17 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。